STAT3 and non-small cell lung carcinoma: A cell assay of non-small cell lung cancer (NSCLC) revealed that apatinib triggered autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer [46].